Updated time: 2024-03-06 15:11:26
28A-1050824
2020-05-05
US 10000747 B2、TW I706035、US 10407673 B2、KR 102166120、AU 2017315677、、JP 6965350、IN 479949
Endoglycosidase S2 (EndoS2) mutants are selected from Streptococcus Pyogenes, which is used to synthesize glycopeptides or glycoproteins carrying a broad range of N-glycans of high mannose, hybrid, and complex types. A mutant of EndoS2 includes each mutations in the sequence of a wild-type EndoS2 in a peptide region located within residues 133-143, residues 177-182, residues 184-189, residues 221-231, or residues 227-237, which has a reduced hydrolyzing activity and a high tranglycosylation activity, as compared to those of the wild-type EndoS2. A method for preparing an engineered glycoprotein using the mutant of EndoS2 includes coupling an activated oligosaccharide to a glycoprotein acceptor which makes the homogeneity of the glycans on it, decreasing the difference of biological activities, even having enhancement of effector functions of glycoengineered antibodies.
- The transglycosylation activity is more efficient than EndoS mutants.
- Low hydrolyzing activity and a high tranglycosylation activity can achieve glycoengineering of glycoprotein, and get homogeneous glycan form of it.
- EndoS2 mutants have transglycosylation activity on a broad range of N-glycans of high mannose, hybrid, and complex types of glycopeptides or glycoproteins which is a powerful tool for glycoprotein remodeling.
- It can be applied to manufacture homogeneous antibody with optimized glycan form which can enhance the effector functions, such as higher FcγRIIIA bindings and antibody-dependent cell-mediated cytotoxicity (ADCC) to kill target cell (e.g. cancer cells), even improve the half-life in circulation, or decrease the inflammation, etc.
- Achievement of homogeneity of glycans on glycoproteins.
Chung-Yi Wu、Chi-Huey Wong、Ting Cheng
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Endoglycosidase mutants for glycoprotein remodeling and methods of using it